Asset
ITRACONAZOLE
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT03479411 | phase1 | completed | 2018-02-09 | 2018-06-28 | Pulmatrix Inc. | Safety, Tolerability and Pharmacokinetics of PUR1900 (Itraconazole Powder) in Healthy Volunteers and Adults With Asthma |
| NCT05667662 | phase2 | terminated | 2023-02-01 | 2024-02-27 | Pulmatrix Inc. | Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPA |
FDA applications (0)
This company has no applications containing this asset.